SCHEMBL6197387

SCHEMBL6197387

CCOC(=O)[C@@H]1CCc2ccc(OC)cc2NC1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.42
KDM4E B2RXH2 4/20 0.42
ALDH1A1 P00352 5/20 0.41
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
GAA P10253 2/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 2/20 0.40
MAPKAPK2 P49137 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
LMNA P02545 1/20 0.40
MTNR1A P48039 4/20 0.40
TSHR P16473 1/20 0.40
NQO2 P16083 3/20 0.39
MTNR1B P49286 3/20 0.39
PDE4A P27815 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6197391 1.00 ALOX15 (0.42) ALOX15KDM4EALDH1A1POLBTDP1
SCHEMBL6197384 1.00 ALOX15 (0.42) ALOX15KDM4EALDH1A1POLBTDP1
SCHEMBL17049209 0.88 ALDH1A1 (0.48) ALOX15KDM4EALDH1A1POLBTDP1
SCHEMBL4623734 0.84 SIRT1 (0.46) ALDH1A1HPGDHSD17B10MTNR1AMTNR1B
SCHEMBL6200356 0.84 CASP1 (0.43) ALDH1A1MTNR1ANQO2MTNR1BDPP4
SCHEMBL6200359 0.84 CASP1 (0.43) ALDH1A1MTNR1ANQO2MTNR1BDPP4
SCHEMBL6137895 0.84 CASP1 (0.43) ALDH1A1MTNR1ANQO2MTNR1BDPP4
SCHEMBL6414533 0.82 MTNR1A (0.46) KMT2AMTNR1ANQO2MTNR1B
SCHEMBL6414529 0.82 MTNR1A (0.46) KMT2AMTNR1ANQO2MTNR1B
SCHEMBL7945190 0.81 ALDH1A1 (0.48) ALOX15KDM4EALDH1A1POLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050234041-A1 Substituted 1-benzazepines and derivatives thereof BIOPORT R&D, INC. 2005-10-20 US disclosed
EP-1392317-A4 SUBSTITUTED 1-BENZAZEPINES AND DERIVATIVES THEREOF ANTEXPHARMA INC (US) 2005-10-19 EP disclosed
EP-1392317-A2 SUBSTITUTED 1-BENZAZEPINES AND DERIVATIVES THEREOF Antexpharma, Inc. (US) 2004-03-03 EP disclosed
US-6514965-B1 For treating bacterial infections ANTEX PHARMA INC. 2003-02-04 US disclosed
WO-2002100327-A2 SUBSTITUTED 1-BENZAZEPINES AND DERIVATIVES THEREOF ANTEXPHARMA, INC. (US) 2002-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234041-A1 Substituted 1-benzazepines and derivatives thereof BAK1, BAD, BAX ALOX15 1153/4885KDM4E 278/4885ALDH1A1 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.